The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Amyloidosis and Alzheimer’s disease
Abstract
Alzheimer's disease (AD) is the most frequent type of amyloidosis in humans and the commonest form of dementia. Extracellular Abeta amyloid deposits in the form of amyloid plaques and cerebral amyloid angiopathy as well as intraneuronal neurofibrillary tangles co-exist in the brain parenchyma of AD patients, the cognitive areas being the most severely affected. This review focuses on the potential role of amyloid in the development of neurodegeneration and presents studies of AD and other unrelated inherited dementia syndromes associated with neuronal loss and amyloid deposition in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inefficient clearance of A, caused by impaired blood-brain barrier crossing into the circulation, seems to be a major cause of A accumulation in the brain of late-onset Alzheimer's disease patients and hereditary cerebral hemorrhage with amyloidosis Dutch type.”
From Lipoprotein Receptor-Related Protein-1 Mediates Amyloid-β-Mediated Cell Death of Cerebrovascular Cells (2007) · cites this paper as [2]
Citations
Cites
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Self-citationChartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214
Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
William Rebeck, G., Reiter, J. S., Strickland, D. K., & Hyman, B. T. (1993) · Neuron · doi:10.1016/0896-6273(93)90070-8 · Cited by 1,107
Ma, J., Yee, A., Brewer, H. B., Das, S., & Potter, H. (1994) · Nature · doi:10.1038/372092a0 · Cited by 871
Research works printed but not linked: 64
- Dobson, 1999, Protein misfolding, evolution and disease, Trends Biochem. Sci., 24, 329, 10.1016/S0968-0004(99)01445-0 · DOI · Paper page
- Ferreira, 2001, Protein dynamics, folding and misfolding: From basic physical chemistry to human conformational diseases, FEBS Lett., 498, 129, 10.1016/S0014-5793(01)02491-7 · DOI
- Thomas, 1995, Defective protein folding as a basis of human disease, Trends Biochem. Sci., 20, 456, 10.1016/S0968-0004(00)89100-8 · DOI · Paper page
- Martin, 1999, Molecular basis of the neurodegenerative disorders, N. Engl. J. Med., 340, 1970, 10.1056/NEJM199906243402507 · DOI · Paper page
- Paulson, 2000, Polyglutamine disease and neuronal cell death, Proc. Natl. Acad. Sci. USA, 97, 12957, 10.1073/pnas.210395797 · DOI
- Rajagolapan, 2001, Alpha synuclein aggregation: is it the toxic gain of function responsible for the neurodegeneration in Parkinson’s disease, Mech. Ageing Dev., 122, 1499, 10.1016/S0047-6374(01)00283-4 · DOI
- Cohen, 1999, Protein misfolding and Prion diseases, J. Mol. Biol., 293, 313, 10.1006/jmbi.1999.2990 · DOI
- Prusiner, 2001, Shattuck lecture: Neurodegenerative diseases and prions, N. Engl. J. Med., 344, 1548, 10.1056/NEJM200105173442006 · DOI · Paper page
- Westermark, 1999, Nomenclature of amyloid fibril proteins, Amyloid, 6, 62
- Huilgol, 1998, Cytokeratins in primary cutaneous amyloidosis, Australas J. Dermatol., 39, 81, 10.1111/j.1440-0960.1998.tb01253.x · doi:10.1111/j.1440-0960.1998.tb01253.x
- Vidal, 1999, A stop-codon mutation in the BRI gene associated with familial British dementia, Nature, 399, 776, 10.1038/21637 · DOI · Paper page
- Häggqvist, 1999, Medin: An integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid, Proc. Natl. Acad. Sci. USA, 96, 8669, 10.1073/pnas.96.15.8669 · DOI · Paper page
- Schmitt-Bernard, 2000, In vitro creation of amyloid fibrils from native Arg124Cys mutated βGH3(110-131) peptides, and its relevance for lattice corneal amyloid dystrophy type I, Biochem. Biophys. Res. Commun., 273, 649, 10.1006/bbrc.2000.2955 · doi:10.1006/bbrc.2000.2955
- Wisniewski, 1997, Biology of Aβ amyloid in Alzheimer’s disease, Neurobiol. Dis., 4, 313, 10.1006/nbdi.1997.0147 · DOI · Paper page
- Selkoe, 2001, Alzheimer’s disease: genes, proteins, therapy, Physiol. Rev., 81, 741, 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- Goldgaber, 1987, Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease, Science, 235, 877, 10.1126/science.3810169 · DOI · Paper page
- Robakis, 1987, Molecular cloning and characterization of a cDNA encoding the neuritic plaque amyloid peptides, Proc. Natl. Acad. Sci. USA, 84, 4190, 10.1073/pnas.84.12.4190 · DOI · Paper page
- Vigo-Pelfrey, 1993, Characterization of β-amyloid peptide from human cerebrospinal fluid, J. Neurochem., 61, 1965, 10.1111/j.1471-4159.1993.tb09841.x · DOI · Paper page
- Ghiso, 1997, Alzheimer’s soluble amyloid β is a normal component of human urine, FEBS Lett., 408, 105, 10.1016/S0014-5793(97)00400-6 · DOI
- Tabaton, 1994, Soluble amyloid β-protein is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid, Biochem. Biophys. Res. Commun., 200, 1598, 10.1006/bbrc.1994.1634 · DOI
- Nästrand, 1994, Relative abundance of Alzheimer Aβ amyloid peptide variants in Alzheimer disease and normal aging, Proc. Natl. Acad. Sci. USA, 91, 8378, 10.1073/pnas.91.18.8378 · DOI · Paper page
- Teller, 1996, Presence of soluble amyloid β-peptide precedes amyloid plaque formation in Down’s syndrome, Nat. Med., 2, 93, 10.1038/nm0196-93 · DOI · Paper page
- Zlokovic, 1996, Gp330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer’s Amyloid β at the blood–brain and blood–cerebrospinal fluid barriers, Proc. Natl. Acad. Sci. USA, 93, 4229, 10.1073/pnas.93.9.4229 · DOI · Paper page
- van Duinen, 1987, Hereditary cerebral Hemorrhage with amyloidosis in patients of Dutch origin is related to Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 84, 5991, 10.1073/pnas.84.16.5991 · DOI · Paper page
- Luyendijk, 1964, Intracerebral haematomas. A clinical study of 40 surgical cases, Psychiat. Neurol. Neurochir., 67, 445
- Luyendijk, 1988, Hereditary cerebral hemorrhage caused by cortical amyloid angiopathy, J. Neurol. Sci., 85, 267, 10.1016/0022-510X(88)90186-4 · DOI
- Haan, 1989, Hereditary cerebral hemorrhage with amyloidosis-Dutch type: clinical characteristics, Clin. Neurol. Neurosurg., 91, 285, 10.1016/0303-8467(89)90003-6 · DOI
- Wattendorff, 1982, Familial cerebral amyloid angiopathy presenting as recurrent cerebral hemorrhage, J. Neurol. Sci., 55, 121, 10.1016/0022-510X(82)90094-6 · DOI · Paper page
- Levy, 1990, Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type, Science, 248, 1124, 10.1126/science.2111584 · DOI · Paper page
- Wisniewski, 1991, Peptides homologous to the amyloid protein of Alzheimer’s disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation, Biochem. Biophys. Res. Commun., 173, 1247, 10.1016/0006-291X(91)91706-I · DOI · Paper page
- Miravalle, 2000, Substitutions at codon 22 of Alzheimer’s Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells, J. Biol. Chem., 275, 27110, 10.1016/S0021-9258(19)61486-9 · doi:10.1016/s0021-9258(19)61486-9 · Paper page
- Melchor, 2000, Charge alterations of E22 enhance the pathogenic properties of amyloid beta protein, J. Neurochem., 74, 2209, 10.1046/j.1471-4159.2000.0742209.x · DOI
- Kamino, 1992, Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region, Am. J. Hum. Genet., 51, 998
- Bugiani, 1998, A new AβPP mutation produces hereditary cerebral hemorrhage in an Italian kindred, Neurobiol. Aging, 19, S238
- Tagliavini, 1999, A new AβPP mutation related to hereditary cerebral hemorrhage, Alzheimer’s Rep., 2, 23
- Hendriks, 1992, Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene, Nat. Genet., 1, 218, 10.1038/ng0692-218 · DOI · Paper page
- Eckman, 1997, A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of Aβ42(43), Hum. Mol. Genet., 6, 2087, 10.1093/hmg/6.12.2087 · DOI · Paper page
- Murrell, 1991, A mutation in the amyloid precursor protein associated with hereditary Alzheimer’s disease, Science, 254, 97, 10.1126/science.1925564 · DOI · Paper page
- Checler, 1999, Presenilins: Multifunctional proteins involved in Alzheimer’s disease pathology, IUBMB Life, 48, 33, 10.1080/713803480 · DOI
- Saunders, 1993, Apolipoprotein E epsilon 4 allele distributions in late-onset Alzheimer’s disease and in other amyloid-forming diseases, Lancet, 342, 710, 10.1016/0140-6736(93)91709-U · DOI · Paper page
- Mayeux, 1993, The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease, Ann. Neurol., 34, 752, 10.1002/ana.410340527 · DOI · Paper page
- Ueki, 1993, A high frequency of apolipoprotein E4 isoprotein in Japanese patients with late-onset nonfamilial Alzheimer’s disease, Neurosci. Lett., 163, 166, 10.1016/0304-3940(93)90373-S · DOI
- Mahley, 1999, Apolipoprotein E: from atherosclerosis to Alzheimer’s disease and beyond, Curr. Opin. Lipidol., 10, 207, 10.1097/00041433-199906000-00003 · DOI · Paper page
- Strittmatter, 1993, Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc. Natl. Acad. Sci. USA, 90, 1977, 10.1073/pnas.90.5.1977 · DOI · Paper page
- Wisniewski, 1993, Apolipoprotein E: binding to soluble Alzheimer’s beta-amyloid, Biochem. Biophys. Res. Commun., 192, 359, 10.1006/bbrc.1993.1423 · DOI · Paper page
- Strittmatter, 1994, Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype, Exp. Neurol., 125, 163, 10.1006/exnr.1994.1019 · DOI · Paper page
- Wisniewski, 1994, Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro, Am. J. Pathol., 145, 1030
- Holtzman, 2000, Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer’s disease model, Ann. Neurol., 47, 739, 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
- Grundke-Iqbal, 1986, Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer’s cytoskeletal pathology, Proc. Natl. Acad. Sci. USA, 83, 4913, 10.1073/pnas.83.13.4913 · DOI · Paper page
- Wood, 1986, Neurofibrillary tangles in Alzheimer’s disease share antigenic determinants with the axonal microtubule-associated protein tau, Proc. Natl. Acad. Sci. USA, 83, 4040, 10.1073/pnas.83.11.4040 · DOI · Paper page
- Kosik, 1986, Microtubule-associated protein, tau, is a major antigenic component of paired helical filaments in Alzheimer’s disease, Proc. Natl. Acad. Sci. USA, 83, 4044, 10.1073/pnas.83.11.4044 · DOI · Paper page
- Ghiso, 2001, Chromosome 13 dementia syndromes as models of neurodegeneration, Amyloid J. Prot. Fold. Dis., 8, 277, 10.3109/13506120108993826 · DOI
- Holton, 2001, Regional distribution of fibrillar and non-fibrillar ABri deposition and its association with neurofibrillary degeneration in Familial British Dementia, Am. J. Pathol., 158, 515, 10.1016/S0002-9440(10)63993-4 · DOI · Paper page
- Holton, 2002, Familial Danish dementia: A novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta, J. Neuropath. Exper. Neurol., 61, 254, 10.1093/jnen/61.3.254 · DOI
- Ghiso, 2001, Systemic amyloid deposits in familial British dementia, J. Biol. Chem., 276, 43909, 10.1074/jbc.M105956200 · DOI
- Joachim, 1989, Amyloid beta-protein deposition in tissues other than brain in Alzheimer’s disease, Nature, 341, 226, 10.1038/341226a0 · DOI · Paper page
- Skodras, 1993, Immunohistochemical localization of amyloid beta-protein deposits in extracerebral tissues of patients with Alzheimer’s disease, Ann. Clin. Lab. Sci., 23, 275
- Wen, 1994, Presence of non-fibrillar amyloid beta protein in skin biopsies of Alzheimer’s disease (AD), Down’s syndrome and non-AD normal persons, Acta Neuropathol., 88, 201, 10.1007/BF00293394 · DOI
- Gudmundsson, 1972, Hereditary cerebral hemorrhage with amyloidosis, Brain, 95, 387, 10.1093/brain/95.2.387 · DOI · Paper page
- Benedikz, 1990, Skin deposits in hereditary cystatin C amyloidosis, Virchows Arch. A, 417, 325, 10.1007/BF01605784 · doi:10.1007/bf01605784
- Ghiso, 1986, Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of γ-trace basic protein (cystatin-C), Proc. Natl. Acad. Sci. USA, 83, 2974, 10.1073/pnas.83.9.2974 · DOI · Paper page
- Levy, 1989, Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin-C gene, an inhibitor of cysteine proteases, J. Exp. Med., 169, 1771, 10.1084/jem.169.5.1771 · DOI · Paper page
- Crawford, 2000, A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer’s disease, Neurology, 55, 763, 10.1212/WNL.55.6.763 · DOI
- Finckh, 2000, Genetic association of a cystatin C gene polymorphism with late onset Alzheimer’s disease, Arch. Neurol., 57, 1579, 10.1001/archneur.57.11.1579 · DOI
Cited by
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
LRP/Amyloid β-Peptide Interaction Mediates Differential Brain Efflux of Aβ Isoforms
Deane, R., Wu, Z., Sagare, A., Davis, J., Du Yan, S., Hamm, K., Xu, F., Parisi, M., LaRue, B., Hu, H. W., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.07.017 · Cited by 828
Deane, R., Wu, Z., & Zlokovic, B. V. (2004) · Stroke · doi:10.1161/01.str.0000143452.85382.d1 · Cited by 392
The role of cerebral amyloid β accumulation in common forms of Alzheimer disease
Gandy, S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25100 · Cited by 385
Melatonin, human aging, and age-related diseases
Karasek, M. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.04.012 · Cited by 380
Metadata
- Authors
- Ghiso, J., & Frangione, B.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 54
- Issue
- 12
- Pages
- 1539-1551
- ISSN
- 0169-409X
- Cited by
- 158
- References
- 18
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amyloidosis and Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/s0169-409x(02)00149-7
- The paper
- Ghiso, J., & Frangione, B. (2002). Amyloidosis and Alzheimer’s disease. Advanced Drug Delivery Reviews. https://doi.org/10.1016/s0169-409x(02)00149-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.